Risk adjustment for health care financing in chronic disease: What are we missing by failing to account for disease severity?

Medical Care

Volumn 51, Issue 8, 2013, Pages 740-747

  Omachi, Theodore A ^a   Gregorich, Steven E ^a   Eisner, Mark D ^a,b   Penaloza, Renee A ^b   Tolstykh, Irina V ^c   Yelin, Edward H ^b   Iribarren, Carlos ^c   Dudley, R Adams ^a,b   Blanc, Paul D ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d Occupational and Environmental Health   (United States)

Author keywords

chronic disease; COPD; financing; health care costs; health care markets; health care reform; risk adjustment; socioeconomic factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODE INDEX SCORE; BODY MASS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; DYSPNEA; DYSPNEA SCALE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HOSPITALIZATION; HOUSEHOLD; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RISK ASSESSMENT; SEX; WALKING;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CHRONIC DISEASE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH EXPENDITURES; HUMANS; INCOME; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ADJUSTMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; UNITED STATES;

EID: 84880756001     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318298082f     Document Type: Article

References (50)

1. Song Z, Safran DG, Landon BE, et al. Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med. 2011;365: 909-918.
2. Robinson JC, Williams T, Yanagihara D. Measurement of and reward for efficiency In California's pay-for-performance program. Health Aff (Millwood). 2009;28:1438-1447.
3. Petersen LA, Pietz K, Woodard LD, et al. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care. 2005;43:61-67.
4. Fisher ES, Shortell SM. Accountable care organizations: accountable for what, to whom, and how. JAMA. 2010;304:1715-1716.
5. Fisher ES, Staiger DO, Bynum JP, et al. Creating accountable care organizations: the extended hospital medical staff. Health Aff (Millwood). 2007;26:w44-w57.
6. Centers for Medicare and Medicaid Services. Medicare Advantage (Medicare+Choice, Average Adjusted per Capita Costs) rates and statistics. Available at: http://www.cms.hhs.gov/MedicareAdvtgSpec RateStats/. Accessed February 29, 2012.
7. Pollack CE, Armstrong K. Accountable care organizations and health care disparities. JAMA. 2011;305:1706-1707.
8. Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health. 2011;65: 26-34.
9. Tabak YP, Johannes RS, Silber JH. Using automated clinical data for risk adjustment: development and validation of six disease-specific mortality predictive models for pay-for-performance. Med Care. 2007;45:789-805.
10. Tabak YP, Sun X, Derby KG, et al. Development and validation of a disease-specific risk adjustment system using automated clinical data. Health Serv Res. 2010;45(pt 1):1815-1835.
11. Kochanek KD, Xu JQ, Murphy SL, et al. Deaths: Preliminary Data for 2009. National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 2011.
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946.
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012.
14. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Pulmonary Disease. Available at: http://www.goldcopd. com. Accessed April 20, 2012. Revised 2011.
15. Salzman SH. The 6-min walk test: clinical and research role, technique, coding, and reimbursement. Chest. 2009;135:1345-1352.
16. Verisk Health, Inc. DxCG Risk Solutions: User's Guide. Waltham, MA: Verisk Health; 2008.
17. Eisner MD, Iribarren C, Yelin EH, et al. Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease. Am J Epidemiol. 2008;167:1090-1101.
18. Petersen LA, Urech TH, Byrne MM, et al. Do financial incentives in a globally budgeted healthcare payment system produce changes in the way patients are categorized? A five-year study. Am J Manag Care. 2007;13:513-522.
19. Rosen AK, Loveland S, Anderson JJ, et al. Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population? Med Care. 2001;39:692-704.
20. Ash AS, Ellis RP, Pope GC, et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev. 2000;21:7-28.
21. Maciejewski ML, Liu CF, Derleth A, et al. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health Serv Res. 2005;40:887-904.
22. Pope GC, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev. 2004;25:119-141.
23. Kronick R, Gilmer T, Dreyfus T, et al. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev. 2000;21:29-64.
24. Dudley RA, Medlin CA, Hammann LB, et al. The best of both worlds? Potential of hybrid prospective/concurrent risk adjustment. Med Care. 2003;41:56-69.
25. Zhao Y, Ash AS, Ellis RP, et al. Disease burden profiles: an emerging tool for managing managed care. Health Care Manag Sci. 2002;5: 211-219.
26. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-187.
27. Rasekaba T, Lee AL, Naughton MT, et al. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009;39: 495-501.
28. Pichurko BM. Exercising your patient: which test(s) and when? Respir Care. 2012;57:100-110; discussion 110-103.
29. Mahler DA, Ward J, Waterman LA, et al. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest. 2009;136:1473-1479.
30. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54: 581-586.
31. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005;128: 3810-3816.
32. Faganello MM, Tanni SE, Sanchez FF, et al. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci. 2010;339:10-14.
33. Marin JM, Carrizo SJ, Casanova C, et al. Prediction of risk of COPD exacerbations by the BODE index. Respir Med. 2009;103: 373-378.
34. Ray GT, Collin F, Lieu T, et al. The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000;57:92-109.
35. Fireman B, Bartlett J, Selby J. Can disease management reduce health care costs by improving quality? Health Aff (Millwood). 2004;23: 63-75.
36. Correia EW. Accountable care organizations: the proposed regulations and the prospects for success. Am J Manag Care. 2011;17:560-568.
37. Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1: 185-202.
38. Powers CA, Meyer CM, Roebuck MC, et al. Predictive modeling of total healthcare costs using pharmacy claims data: a comparison of alternative econometric cost modeling techniques. Med Care. 2005;43: 1065-1072.
39. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005; 24:465-488.
40. Vittinghoff E, Glidden DV, Shiboski SC, et al. Regression Methods in Biostatistics: Linear, Logistic, Survivial, and Repeated Measures Models. 2nd ed. New York: Springer Science & Business Media Inc.; 2011.
41. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-592.
42. Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J Suppl. 2003;41:36s-45s.
43. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155: 1278-1282.
44. Hardin JW, Hilbe JM. Generalized Linear Models and Extensions. 3rd ed. College Station, TX: Stata Press; 2012.
45. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143: 29-36.
46. Blumenthal D, Tavenner M. The "meaningful use" regulation for electronic health records. N Engl J Med. 2010;363:501-504.
47. Diamond E, French K, Gronkiewicz C, et al. Electronic medical records: a practitioner's perspective on evaluation and implementation. Chest. 2010;138:716-723.
48. Faulconer ER, de Lusignan S. An eight-step method for assessing diagnostic data quality in practice: chronic obstructive pulmonary disease as an exemplar. Inform Prim Care. 2004;12:243-254.
49. Hsia DC, Krushat WM, Fagan AB, et al. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med. 1988;318:352-355.
50. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. Jama. 2002;287:2519-2527.